Rapid methods for utilizing cell kinetics for treatment in the C3H/He spontaneous mammary tumor: effects of vincristine

L. M. Schiffer, Paul G Braunschweiger, L. Poulakos

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

For many years oncologists have been frustrated by the apparent lack of progress in obtaining clinically useful cell kinetic measurements of human solid tumors. The technique of in vivo administration of tritiated thymidine (3H-TdR) followed by multiple biopsies, to determine the fraction of labeled mitoses, has largely remained unchanged during the past 15 years, and the limitations of this procedure are well known and do not need re-emphasis. Although in vitro measurement of 3H-TdR-labeling indices (LI) and in vitro estimation of DNA synthesis time (Ts) have been practiced for many years, there have been few controlled studies to determine whether the in vitro results are really comparable to those found in vivo. In addition, only indirect measurements of growth fraction (GF) have been possible. It was with these problems in mind that our laboratory began investigations into rapid techniques with clinical applicability for measuring cytokinetic parameters. From the start it was understood that our results probably would not detect the nuances and would be a pragmatic approach to the problem. The mode chosen for the development of techniques was the spontaneous mammary tumor of the C3H/He mouse. The spontaneous tumor model was chosen because of its relatively well differentiated histology, low GF, and potential variation in growth rates, and because the vascular patterns are far different from transplantable tumors. The limitation of this model is primarily that of relatively few tumor animals. This report will describe the comparison between in vitro and in vivo studies of the measured cytokinetic parameters which include: number of cells in DNA synthesis, Ts, estimate of GF, and the derived parameters of cell-cycle time (Tc) and potential doubling time (Tpot). Since these in vitro studies are applicable at the point-in-time of the biopsy, the perturbations of the tumor cytokinetics by drug or radiation therapy can be experimentally determined. A recent study in our laboratory showed that a time-sequenced course of vincristine (VCR) and cyclophosphamide (CYT) would cure an otherwise lethal transplantable T1699 tumor guided by the methods described in this paper; this study will be described in detail later. This report will include initial studies of the effects of VCR on the C3H/He spontaneous mammary tumor and a comment about some of the potential uses to which these techniques may be put.

Original languageEnglish
Pages (from-to)1913-1924
Number of pages12
JournalCancer Treatment Reports
Volume60
Issue number12
StatePublished - Dec 1 1976
Externally publishedYes

Fingerprint

Vincristine
Breast Neoplasms
Neoplasms
Growth
Therapeutics
Biopsy
Inbred C3H Mouse
DNA
Mitosis
Cyclophosphamide
Thymidine
Blood Vessels
Histology
Cell Cycle
Radiotherapy
Cell Count
In Vitro Techniques
Drug Therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Rapid methods for utilizing cell kinetics for treatment in the C3H/He spontaneous mammary tumor : effects of vincristine. / Schiffer, L. M.; Braunschweiger, Paul G; Poulakos, L.

In: Cancer Treatment Reports, Vol. 60, No. 12, 01.12.1976, p. 1913-1924.

Research output: Contribution to journalArticle

Schiffer, L. M. ; Braunschweiger, Paul G ; Poulakos, L. / Rapid methods for utilizing cell kinetics for treatment in the C3H/He spontaneous mammary tumor : effects of vincristine. In: Cancer Treatment Reports. 1976 ; Vol. 60, No. 12. pp. 1913-1924.
@article{fe2baf9cc97a41e7adbc60b848a22c3c,
title = "Rapid methods for utilizing cell kinetics for treatment in the C3H/He spontaneous mammary tumor: effects of vincristine",
abstract = "For many years oncologists have been frustrated by the apparent lack of progress in obtaining clinically useful cell kinetic measurements of human solid tumors. The technique of in vivo administration of tritiated thymidine (3H-TdR) followed by multiple biopsies, to determine the fraction of labeled mitoses, has largely remained unchanged during the past 15 years, and the limitations of this procedure are well known and do not need re-emphasis. Although in vitro measurement of 3H-TdR-labeling indices (LI) and in vitro estimation of DNA synthesis time (Ts) have been practiced for many years, there have been few controlled studies to determine whether the in vitro results are really comparable to those found in vivo. In addition, only indirect measurements of growth fraction (GF) have been possible. It was with these problems in mind that our laboratory began investigations into rapid techniques with clinical applicability for measuring cytokinetic parameters. From the start it was understood that our results probably would not detect the nuances and would be a pragmatic approach to the problem. The mode chosen for the development of techniques was the spontaneous mammary tumor of the C3H/He mouse. The spontaneous tumor model was chosen because of its relatively well differentiated histology, low GF, and potential variation in growth rates, and because the vascular patterns are far different from transplantable tumors. The limitation of this model is primarily that of relatively few tumor animals. This report will describe the comparison between in vitro and in vivo studies of the measured cytokinetic parameters which include: number of cells in DNA synthesis, Ts, estimate of GF, and the derived parameters of cell-cycle time (Tc) and potential doubling time (Tpot). Since these in vitro studies are applicable at the point-in-time of the biopsy, the perturbations of the tumor cytokinetics by drug or radiation therapy can be experimentally determined. A recent study in our laboratory showed that a time-sequenced course of vincristine (VCR) and cyclophosphamide (CYT) would cure an otherwise lethal transplantable T1699 tumor guided by the methods described in this paper; this study will be described in detail later. This report will include initial studies of the effects of VCR on the C3H/He spontaneous mammary tumor and a comment about some of the potential uses to which these techniques may be put.",
author = "Schiffer, {L. M.} and Braunschweiger, {Paul G} and L. Poulakos",
year = "1976",
month = "12",
day = "1",
language = "English",
volume = "60",
pages = "1913--1924",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Rapid methods for utilizing cell kinetics for treatment in the C3H/He spontaneous mammary tumor

T2 - effects of vincristine

AU - Schiffer, L. M.

AU - Braunschweiger, Paul G

AU - Poulakos, L.

PY - 1976/12/1

Y1 - 1976/12/1

N2 - For many years oncologists have been frustrated by the apparent lack of progress in obtaining clinically useful cell kinetic measurements of human solid tumors. The technique of in vivo administration of tritiated thymidine (3H-TdR) followed by multiple biopsies, to determine the fraction of labeled mitoses, has largely remained unchanged during the past 15 years, and the limitations of this procedure are well known and do not need re-emphasis. Although in vitro measurement of 3H-TdR-labeling indices (LI) and in vitro estimation of DNA synthesis time (Ts) have been practiced for many years, there have been few controlled studies to determine whether the in vitro results are really comparable to those found in vivo. In addition, only indirect measurements of growth fraction (GF) have been possible. It was with these problems in mind that our laboratory began investigations into rapid techniques with clinical applicability for measuring cytokinetic parameters. From the start it was understood that our results probably would not detect the nuances and would be a pragmatic approach to the problem. The mode chosen for the development of techniques was the spontaneous mammary tumor of the C3H/He mouse. The spontaneous tumor model was chosen because of its relatively well differentiated histology, low GF, and potential variation in growth rates, and because the vascular patterns are far different from transplantable tumors. The limitation of this model is primarily that of relatively few tumor animals. This report will describe the comparison between in vitro and in vivo studies of the measured cytokinetic parameters which include: number of cells in DNA synthesis, Ts, estimate of GF, and the derived parameters of cell-cycle time (Tc) and potential doubling time (Tpot). Since these in vitro studies are applicable at the point-in-time of the biopsy, the perturbations of the tumor cytokinetics by drug or radiation therapy can be experimentally determined. A recent study in our laboratory showed that a time-sequenced course of vincristine (VCR) and cyclophosphamide (CYT) would cure an otherwise lethal transplantable T1699 tumor guided by the methods described in this paper; this study will be described in detail later. This report will include initial studies of the effects of VCR on the C3H/He spontaneous mammary tumor and a comment about some of the potential uses to which these techniques may be put.

AB - For many years oncologists have been frustrated by the apparent lack of progress in obtaining clinically useful cell kinetic measurements of human solid tumors. The technique of in vivo administration of tritiated thymidine (3H-TdR) followed by multiple biopsies, to determine the fraction of labeled mitoses, has largely remained unchanged during the past 15 years, and the limitations of this procedure are well known and do not need re-emphasis. Although in vitro measurement of 3H-TdR-labeling indices (LI) and in vitro estimation of DNA synthesis time (Ts) have been practiced for many years, there have been few controlled studies to determine whether the in vitro results are really comparable to those found in vivo. In addition, only indirect measurements of growth fraction (GF) have been possible. It was with these problems in mind that our laboratory began investigations into rapid techniques with clinical applicability for measuring cytokinetic parameters. From the start it was understood that our results probably would not detect the nuances and would be a pragmatic approach to the problem. The mode chosen for the development of techniques was the spontaneous mammary tumor of the C3H/He mouse. The spontaneous tumor model was chosen because of its relatively well differentiated histology, low GF, and potential variation in growth rates, and because the vascular patterns are far different from transplantable tumors. The limitation of this model is primarily that of relatively few tumor animals. This report will describe the comparison between in vitro and in vivo studies of the measured cytokinetic parameters which include: number of cells in DNA synthesis, Ts, estimate of GF, and the derived parameters of cell-cycle time (Tc) and potential doubling time (Tpot). Since these in vitro studies are applicable at the point-in-time of the biopsy, the perturbations of the tumor cytokinetics by drug or radiation therapy can be experimentally determined. A recent study in our laboratory showed that a time-sequenced course of vincristine (VCR) and cyclophosphamide (CYT) would cure an otherwise lethal transplantable T1699 tumor guided by the methods described in this paper; this study will be described in detail later. This report will include initial studies of the effects of VCR on the C3H/He spontaneous mammary tumor and a comment about some of the potential uses to which these techniques may be put.

UR - http://www.scopus.com/inward/record.url?scp=0017209434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017209434&partnerID=8YFLogxK

M3 - Article

C2 - 1026346

AN - SCOPUS:0017209434

VL - 60

SP - 1913

EP - 1924

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 12

ER -